Observation on Clinical Effect of Modified Wu-Fu Ma-Xin Gui-Jiang Decoction for Treatment of Nonspecific Low Back Pain / 世界科学技术-中医药现代化

ABSTRACT

This study was aimed to observe clinical effect of Wu-Fu Ma-Xin Gui-Jiang (WFMXGJ) decoction treatment for patients with nonspecific low back pain. A total of 60 nonspecific low back pain cases were selected and randomly divided into the treatment group and the control group, with 30 cases in each group. Patients in the treatment group were treated with modified WFMXGJ decoction, while cases in the control group were given rou-tine treatment of oral administration of nimesulide sustained-release tablets. Seven days were one treatment course. Comparison was made on Visual Analogue Scale/Score (VAS), clinical symptoms and body signs before and after treatment between two groups. The results showed that compared with pretreatment, low back pain were relieved with obviously improved VAS among patients in both groups (P<0.05). However, there was no significant difference between the treatment group and the control group. In the treatment group, acute low back pain VAS was obviously improved than the chronic low back pain VAS (P<0.05). There was no statistical significance between the acute and chronic low back pain in the control group. In the treatment group, the total effective rate was 93.33%;and the con-trol group was 73.33%. The clinical effect of treatment group was more significant than the control group (P<0.05). There was no statistical significance on acute and chronic low back pain in the treatment group and the control group. The recurrent rate of the treatment group was significantly lower than the control group (P<0.05). In the treatment group, the recurrence rate of chronic low back pain patients was higher (P<0.05). There was no significant difference on the comparison between acute and chronic low back pain in the control group. It was concluded that modified WFMXGJ decoction had obvious therapeutic effect on treatment of nonspecific low back pain, especially for the improvement of acute low back pain, with non-toxic side effects and low recurrence rate. It is worthy of fur-ther research and promotion.